DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1DICLOFENAC SODIUM AND MISOPROSTOL
02 1NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
01 1200540
02 1204206
01 2No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
Drug : NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 204206
Country : US
Patented : No
DICLOFENAC SODIUM; MISOPROSTOL
Drug : DICLOFENAC SODIUM AND MISOPROSTOL
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 200540
Country : US
Patented : No
